The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bayer Health; Bayer Health; Bayer Health; Bayer Health
Consulting or Advisory Role - Bayer Health; Bayer Health; Bayer Health; Bayer Health
Research Funding - Bayer Health (Inst); Bayer Health (Inst); Bayer Health (Inst); Bayer Health (Inst)
Travel, Accommodations, Expenses - Bayer Health; Bayer Health; Bayer Health; Bayer Health
 
Honoraria - Bayer Health; Bayer Health; Bayer Health; Bayer Health
Consulting or Advisory Role - Bayer Health; Bayer Health; Bayer Health; Bayer Health
Travel, Accommodations, Expenses - Bayer Health; Bayer Health; Bayer Health; Bayer Health

Regorafenib with TAS-102 (REGOTAS) in metastatic colorectal cancer patients who progressed after at least two standard therapies: Efficacy and safety results of a multicenter phase I study (REMETY).
 
Markus H. Moehler
Honoraria - Amgen; Amgen; Amgen; Amgen; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Lilly/ImClone; Lilly/ImClone; Lilly/ImClone; Lilly/ImClone; Merck Serono; Merck Serono; Merck Serono; Merck Serono; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech; Servier; Servier; Servier; Servier; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; Lilly; Lilly; Lilly; Lilly; Merck Serono; Merck Serono; Merck Serono; Merck Serono; MSD; MSD; MSD; MSD; Nordic Group; Nordic Group; Nordic Group; Nordic Group; Pfizer; Pfizer; Pfizer; Pfizer; Roche; Roche; Roche; Roche; SERVIER; SERVIER; SERVIER; SERVIER; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Yakult Pharmaceutical; Yakult Pharmaceutical; Yakult Pharmaceutical; Yakult Pharmaceutical
Research Funding - Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Jennerex (Inst); Jennerex (Inst); Jennerex (Inst); Jennerex (Inst); Leap Therapeutics (Inst); Leap Therapeutics (Inst); Leap Therapeutics (Inst); Leap Therapeutics (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); MSD (Inst); MSD (Inst); MSD (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Amgen; ASCO; ASCO; ASCO; ASCO; Bayer; Bayer; Bayer; Bayer; ESMO; ESMO; ESMO; ESMO; German Cancer Society; German Cancer Society; German Cancer Society; German Cancer Society; Merck Serono; Merck Serono; Merck Serono; Merck Serono; MSD; MSD; MSD; MSD; Roche; Roche; Roche; Roche
 
Alexander Stein
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA; MSD; MSD; MSD; MSD; Roche; Roche; Roche; Roche
Speakers' Bureau - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Lilly; Lilly; Lilly; Lilly; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi; Servier; Servier; Servier; Servier
Research Funding - Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); SERVIER (Inst); SERVIER (Inst); SERVIER (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA; Roche; Roche; Roche; Roche
 
Jorg Trojan
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Lilly; Lilly; Lilly; Lilly; Merck Serono; Merck Serono; Merck Serono; Merck Serono; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; Roche; Roche; Roche; Roche; SERVIER; SERVIER; SERVIER; SERVIER
Speakers' Bureau - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Novartis; Novartis; Novartis; Novartis
 
Jens Uwe Marquardt
No Relationships to Disclose
 
Julia Quidde
No Relationships to Disclose
 
Oliver Waidmann
Honoraria - Bayer Health; Bayer Health; Bayer Health; Bayer Health; SERVIER; SERVIER; SERVIER; SERVIER
Consulting or Advisory Role - Bayer Health; Bayer Health; Bayer Health; Bayer Health; SERVIER; SERVIER; SERVIER; SERVIER
Travel, Accommodations, Expenses - SERVIER; SERVIER; SERVIER; SERVIER
 
Arndt Weinmann
No Relationships to Disclose
 
Marcus Woerns
Honoraria - Bayer Health; Bayer Health; Bayer Health; Bayer Health
Consulting or Advisory Role - Bayer Health; Bayer Health; Bayer Health; Bayer Health
Research Funding - Bayer Health (Inst); Bayer Health (Inst); Bayer Health (Inst); Bayer Health (Inst)
Travel, Accommodations, Expenses - Bayer Health; Bayer Health; Bayer Health; Bayer Health
 
Helge Schroeder
No Relationships to Disclose
 
Martin Maenz
No Relationships to Disclose
 
Aysun Karatas
No Relationships to Disclose
 
Friedrich Foerster
No Relationships to Disclose